A novel group of ovarian toxicants: The psoralens

Journal of Biochemical and Molecular Toxicology

Volumn 13, Issue 3-4, 1999, Pages 195-203

  Diawara, M M ^a   Chavez, K J ^a   Hoyer, P B ^b   Williams, D E ^c   Dorsch, J ^a   Kulkosky, P ^a   Franklin, M R ^d  

^a Malik and Seeme Hasan School of Business   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

17 Estradiol; 5 Methoxypsoralen; 8 Methoxypsoralen; Birthrate; CYP1A1; Ovarian Toxicity; UGT1A6

Indexed keywords

PSORALEN DERIVATIVE;

ANIMAL; ARTICLE; BODY WEIGHT; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; LITTER SIZE; LIVER; ORGAN SIZE; OVARY; PREGNANCY; RAT; UTERUS; WISTAR RAT;

ANIMALS; BODY WEIGHT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LITTER SIZE; LIVER; ORGAN SIZE; OVARY; PREGNANCY; PSORALENS; RATS; RATS, WISTAR; UTERUS;

EID: 0032602601     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-0461(1999)13:3/4<195::aid-jbt10>3.0.co;2-p     Document Type: Article

References (26)

1. Cole RS. Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Studies with phase 1, Escherichia coli and mouse leukemia cells. Biochem Biophys Acta 1970;217:30-39.
2. Murray RDH, Mendez J, Brown SA. The Natural Coumarins. Chichester, UK: Wiley; 1982.
3. Trumble JT, Moar WT, Brewer MJ, Carson WG. Impact of UV radiation on activity of linear furanocoumarins and Bacillus thuringiensis var kurstaki against Spodoptera exigua: implications for tritrophic interactions. J Chem Ecol 1991;17:973-987.
4. Beier RC. Natural pesticides and bioactive components in foods. Rev Environ Contam Toxicol 1990;113:47-137.
5. Berenbaum MR. Coumarins. In: Rosenthal GA, Berenbaum MR, editors., Volume 1, Herbivores their interactions with secondary plant metabolites, the chemical participants. New York: Academic; 1991. pp 221-249.
6. Diawara MM, Trumble JT. Linear furanocoumarins. In: D'Mello JPF, editor. Handbook on plant and fungal toxicants. Boca Raton (EL): CRC Press; 1997. pp 175-189.
7. Musajo L, Rodighiero G. The skin-photosensitizing furanocoumarins. Experientia 1962;! 8:153-200.
8. Van Scott EJ. Therapy of psoriasis. JAMA 1976;235:197-198.
9. Scott BR, Pathak MA, Mohm GR. Molecular and genetic basis of furanocoumarin reactions. Mutat Res 1976;39:29-74.
10. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. Photochem Photobiol B 1992;14:3-33.
11. Chadwick CA, Potten CS, Cohen AJ, Young AR. The time of onset and duration of 5-methoxypsoralen photochem-oprotection from UVR-induced DNA damage in human skin. Br J Dermatol 1994;131:483-194.
12. Ehrsson H, Wallin I, Ros AM, Eksborg S, Berg M. Food-induced increase in bioavailability of 5-methoxypsoralen. Eur J Clin Pharmacol 1994;46:375-377.
13. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979;300:809-813.
14. Grekin DA, Epstein JH. Psoralens, UVA (PUVA) and photocarcinogenesis. Photochem Photobiol 1981;33:957-960.
15. Calzavara-Pinton P, Carlino A, Manfedi E, Semeraro F, Zane C, Panfilis G. Ocular side effects of PLTVA-treated patients refusing eye sun protection. Acta Derm Venereol Suppl Stockh 1994;186:164-165.
16. Young AR. Photocarcinogenicity of psoralens used in PUVA treatment-present status in mouse and man. J Photochem Photobiol B-Biol 1990;6:237-247.
17. Boesen JJ, Stuivenberg S, Thyssens CH, Panneman H, Darroudi F, Lohman PH, Simons JW. Stress response induced by DNA damage leads to specific, delayed and untargeted mutations. Mol Gen Genet 1992;234:217-227.
18. Ashwood-Smith MJ, Poulon GA, Barker M, Mildenberger M. 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and cleistogenic properties. Nature 1980;285:407-409.
19. International Agency for Research on Skin Cancer (IARSC). Evaluation of the carcinogenic risk of chemicals to humans. Supplement 4: Chemicals, industrial process and industries associated with cancer in humans. International Agency for Research on Cancer. Lyon, France. 1983.
20. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet radiation (PUVA). N Engl J Med 1997;336:1041-1045.
21. Backstrom M, Wetterberg L. Influence of psoralen on melatonin formation in rat pineal gland in organ culture. Acta Endocrinol 1977;89:659-666.
22. Grota LJ, Lewy AJ, Goldsmith G, Brown GM. Psoralen increases melatonin levels without U.V. light. Ann NY Acad Sci 1985;453:385-387.
23. Garde E, Micic S, Knudsen K, Angelo HR, Wulf HC. 8-Methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism. Photochem Photobiol 1994;60:475-480.
24. Neal JJ, Wu D. Inhibition of insect cytochromes P450 by furanocoumarins. Pesticide Biochem Physiol 1994;50:43-50.
25. Maenpaa J, Juvonen R, Raunio H, Rautio A, Pelkonen O. Metabolic interactions of methoxsalen and coumarin in humans and mice. Biochem Pharmacol 1994;48:1363-1369.
26. Maenpaa J, Sigusch H, Raunio H, Syngelma T, Vuorela P, Vuorela H, Pelkonen O. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol 1993;45:1035-1042.